Fisher Asset Management
ITOS

Fisher Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Fisher Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-55,722
Closed -$556K – 1049
2025
Q2 		$556K Hold
55,722
– – ﹤0.01% 775
2025
Q1 		$333K Buy
55,722
+20,507
+58% +$151K ﹤0.01% 877
2024
Q4 		$270K Hold
35,215
– – ﹤0.01% 890
2024
Q3 		$360K Hold
35,215
– – ﹤0.01% 804
2024
Q2 		$523K Buy
+35,215
New +$505K ﹤0.01% 777
2023
Q2 		– Sell
-102
Closed -$1.39K – 1185
2023
Q1 		$1.39K Buy
+102
New +$1.83K ﹤0.01% 1124

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Fisher Asset Management's ITOS Position: Q3 2025 in Review

Fisher Asset Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 55,722 shares — an estimated $556K sold.

Fisher Asset Management first reported a position in ITOS in Q1 2023 and held it in 6 quarters. The position peaked at $556K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Fisher Asset Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Fisher Asset Management sold 55,722 iTeos Therapeutics shares in Q3 2025, an estimated $556K.
  • Fisher Asset Management first reported a position in iTeos Therapeutics in Q1 2023 and held it in 6 quarters.
  • Fisher Asset Management's iTeos Therapeutics position peaked at $556K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Fisher Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.